Remote Jobs at Rezolute, Inc.

Rezolute, Inc.

51 - 200 employees

🧬 Biotechnology

💊 Pharmaceuticals

💰 $96.9M Post-IPO Equity - Rezolute on 2025-04

Biotechnology • Pharmaceuticals

Rezolute, Inc. is a biopharmaceutical company focused on developing and delivering novel therapies for rare metabolic disorders, specifically hyperinsulinism. The company’s lead program, ersodetug, has two Phase 3 programs targeting congenital and tumor hyperinsulinism, and Rezolute conducts clinical trials, investigator-initiated studies, and publishes clinical outcomes. Rezolute also engages with patients, investors, and the medical community to improve care and quality of life for affected patients and families.